I
Indaco
Indaco is a Series A to Series C stage investment firm. It has made 14 investments. 35% of their portfolio is in Healthcare. Their most common stage is series-a (41% of deals). Average disclosed round size is $35.3M (across 3 rounds with reported amounts).
Portfolio
14
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
17 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 CamGraphic | Series A | — | Mar 2025 |
 Valo Therapeutics Italy | Unknown | — | Mar 2025 |
 Newronika | Series B | — | Feb 2025 |
 2D Photonics | Series A | — | Feb 2025 |
| CamGraphic | Unknown | — | Jan 2025 |
 Freya Biosciences | Series A | — | Nov 2024 |
| HHoba Therapeutics ApS | Series A | — | Dec 2023 |
 Nouscom | Series C | — | Nov 2023 |
 SibYlla | Series A | — | Oct 2022 |
 Sibylla Biotech | Series A | — | Oct 2022 |
 Innovheart | Series C | $55M | Jan 2022 |
| Sibylla Biotech | Series A | — | Jan 2022 |
| Innovheart | Series B | — | Aug 2020 |
 MainStreaming | Unknown | $6M | May 2019 |
 Cortilia | Unknown | — | — |
 Easyrain | Unknown | — | — |
| AAptadir Therapeutics | Seed | $45M | — |
Top Co-Investors
CDP Venture Capital10 shared
Vesper Holding8 shared
Sony Innovation Fund4 shared
Angelini Ventures3 shared
3B Future Health Fund3 shared
Vi Partners3 shared
Vertis SGR3 shared
Seroba Life Sciences3 shared
Sony Innovation Fund by IGV3 shared
Evolution Equity Partners2 shared
Indaco Venture Partners SGR2 shared
Club degli Investitori2 shared
EIFO2 shared
CE Ventures2 shared
Andera Partners1 shared
Bpifrance1 shared
EQT Life Sciences1 shared
M Ventures1 shared
Revelation Partners1 shared
Versant Ventures1 shared
Last updated: 20 October 2026